AI
Friday, September 02, 2016 5:03:28 PM
IMNP @ Stockcharts
No question a buying opportunity of late at IMNP!
Last 30 day
CEO of Immune Pharmaceuticals Inc (IMNP) Daniel Gedeon Teper bought 937,500 shares of IMNP on 08/04/2016 at an average price of $0.38 a share. The total cost of this purchase was $356,250.
Immune Pharmaceuticals Inc is a clinical stage biopharmaceutical company specializing in the development and commercialization of targeted therapeutics for the treatment of inflammatory diseases and cancer. Immune Pharmaceuticals Inc has a market cap of $13.513 million; its shares were traded at around $0.33 .
http://finance.yahoo.com/news/immune-pharmaceuticals-inc-imnp-ceo-061503523.html;_ylt=A0LEV1IS6slXbe4AiGJXNyoA;_ylu=X3oDMTEyNzYzdHA4BGNvbG8DYmYxBHBvcwM2BHZ0aWQDQjE3OTNfMQRzZWMDc3I-
Investor 100
No question a buying opportunity of late at IMNP!
Last 30 day
CEO of Immune Pharmaceuticals Inc (IMNP) Daniel Gedeon Teper bought 937,500 shares of IMNP on 08/04/2016 at an average price of $0.38 a share. The total cost of this purchase was $356,250.
Immune Pharmaceuticals Inc is a clinical stage biopharmaceutical company specializing in the development and commercialization of targeted therapeutics for the treatment of inflammatory diseases and cancer. Immune Pharmaceuticals Inc has a market cap of $13.513 million; its shares were traded at around $0.33 .
http://finance.yahoo.com/news/immune-pharmaceuticals-inc-imnp-ceo-061503523.html;_ylt=A0LEV1IS6slXbe4AiGJXNyoA;_ylu=X3oDMTEyNzYzdHA4BGNvbG8DYmYxBHBvcwM2BHZ0aWQDQjE3OTNfMQRzZWMDc3I-
Investor 100
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
